Replication of the top 10 most significant polymorphisms from a large blood pressure genome-wide association study of northeastern Han Chinese East Asians

The replication of genome-wide significant association signals in independent populations is a practical approach for characterizing gene-disease relationships. Therefore, we sought to explore the top 10 polymorphisms from a large blood pressure genome-wide association study of northeastern Han Chinese East Asians. This was a hospital-based study involving 1009 patients with essential hypertension and 756 normotensive controls from Qiqihar city, China. Genotyping was conducted with a polymerase chain reaction-ligase detection reaction method. All polymorphisms except for rs6825911 satisfied Hardy–Weinberg equilibrium. Overall, the genotype differences between the patients and controls were significant for rs35444 (P<0.001), rs11191548 (P=0.017) and rs17249754 (P=0.017). The per-minor-allele odds ratios of rs35444, rs11191548 and rs17249754 were 0.54 (95% confidence interval (95% CI): 0.46–0.62; P<0.01), 1.23 (95% CI: 1.07–1.43; P=0.005) and 1.23 (95% CI: 1.07–1.41; P=0.004), respectively. Similarly, the carriers of minor homozygotes had a significant reduction in adjusted systolic and diastolic blood pressure for rs35444 (P<0.01) but an increase for both rs11191548 (P<0.01) and rs17249754 (P<0.04). Further application of the genetic risk score method indicated that subjects with risk scores of 8, 10 and 12–16 had 1.66-fold (95% CI: 1.01–2.72), 1.72-fold (95% CI: 1.03–2.86) and 1.97-fold (95% CI: 1.12–3.46) increases, respectively, in the odds of developing hypertension, and similar increases were also observed for blood pressure. Taken together, our findings demonstrate that although only three of the top 10 polymorphisms were successfully validated in the northeastern Han Chinese population, the genetic risk score analyses led us to more profound insights into the possible joint effects of multiple polymorphisms on hypertension risk and blood pressure variation.

[1]  W. Niu,et al.  Validation of genetic association in apelin–AGTRL1 system with hypertension in a larger Han Chinese population , 2010, Journal of hypertension.

[2]  Nuala A Sheehan,et al.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.

[3]  Pui-Yan Kwok,et al.  A Genetic Risk Score Combining Ten Psoriasis Risk Loci Improves Disease Prediction , 2011, PloS one.

[4]  E. Zomawia,et al.  Multiple Analytical Approaches Reveal Distinct Gene-Environment Interactions in Smokers and Non Smokers in Lung Cancer , 2011, PloS one.

[5]  N. Kato.  Ethnic differences in genetic predisposition to hypertension , 2012, Hypertension Research.

[6]  P. Donnelly,et al.  Replicating genotype–phenotype associations , 2007, Nature.

[7]  T. Ogihara,et al.  Genetics of Hypertension and Cardiovascular Disease , 2011, International journal of hypertension.

[8]  P. O’Reilly,et al.  Genome-wide association study identifies eight loci associated with blood pressure , 2009, Nature Genetics.

[9]  W. Niu,et al.  Association of α-Adducin and G-Protein β3 Genetic Polymorphisms with Hypertension: A Meta-Analysis of Chinese Populations , 2011, PloS one.

[10]  G. Siest,et al.  Genetic determinants of blood pressure regulation , 2005, Journal of hypertension.

[11]  W. Niu,et al.  Confirmation of top polymorphisms in hypertension genome wide association study among Han Chinese. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[12]  W. Niu,et al.  Interactive Association of Five Candidate Polymorphisms in Apelin/APJ Pathway with Coronary Artery Disease among Chinese Hypertensive Patients , 2012, PloS one.

[13]  Tien Yin Wong,et al.  Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians , 2011, Nature Genetics.

[14]  Y. Teo,et al.  Comparing methods for performing trans-ethnic meta-analysis of genome-wide association studies. , 2013, Human molecular genetics.

[15]  P. Elliott,et al.  Blood Pressure Differences Between Northern and Southern Chinese: Role of Dietary Factors: The International Study on Macronutrients and Blood Pressure , 2004, Hypertension.

[16]  H. Schunkert,et al.  Clinical validation of genetic markers for improved risk estimation , 2012, European journal of preventive cardiology.

[17]  W. Niu,et al.  The relationship between apolipoprotein E ɛ2/ɛ3/ɛ4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls , 2009, Hypertension Research.

[18]  Francis Barany,et al.  Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors , 1999, Oncogene.

[19]  W. Niu,et al.  An Updated Meta-Analysis of Endothelial Nitric Oxide Synthase Gene: Three Well-Characterized Polymorphisms with Hypertension , 2011, PloS one.

[20]  Jun Yu,et al.  Strong Association between Two Polymorphisms on 15q25.1 and Lung Cancer Risk: A Meta-Analysis , 2012, PloS one.

[21]  W. Niu,et al.  Contribution of five top whole-genome association signals to hypertension in Han Chinese , 2011, Journal of Human Hypertension.

[22]  Eleazar Eskin,et al.  "Good enough solutions" and the genetics of complex diseases. , 2012, Circulation research.

[23]  Udo Hoffmann,et al.  A Genetic Risk Score Is Associated With Incident Cardiovascular Disease and Coronary Artery Calcium: The Framingham Heart Study , 2012, Circulation. Cardiovascular genetics.

[24]  F. Morón,et al.  A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis , 2008, BMC Genomics.